Cargando…
Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022
BACKGROUND: Between February 2020 and September 2022, SARS-CoV-2 has circulated uninterruptedly throughout Spain. This study analyses COVID-19 infections, hospitalizations, and deaths in Navarre. METHODS: Enhanced epidemiological surveillance and results of seroepidemiological surveys were used to a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gobierno de Navarra. Departamento de Salud
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498135/ https://www.ncbi.nlm.nih.gov/pubmed/37594061 http://dx.doi.org/10.23938/ASSN.1044 |
_version_ | 1785105453419593728 |
---|---|
author | Casado, Itziar Cenoz, Manuel García Egüés, Nerea Burgui, Cristina Martínez-Baz, Iván Castilla, Jesús |
author_facet | Casado, Itziar Cenoz, Manuel García Egüés, Nerea Burgui, Cristina Martínez-Baz, Iván Castilla, Jesús |
author_sort | Casado, Itziar |
collection | PubMed |
description | BACKGROUND: Between February 2020 and September 2022, SARS-CoV-2 has circulated uninterruptedly throughout Spain. This study analyses COVID-19 infections, hospitalizations, and deaths in Navarre. METHODS: Enhanced epidemiological surveillance and results of seroepidemiological surveys were used to analyze COVID-19 infections, hospitalizations, and deaths, based on the vaccination coverage and other preventive measures applied from February 2020 to September 2022. RESULTS: A total of 295,424 COVID-19 cases were confirmed (45% of the population in Navarre); 8,594 required hospital admission (1.3%), 832 were admitted to intensive care units (1.3‰) and 1,725 died (2.6‰). Over the first wave of the pandemic, there were 1,934 hospitalizations and 529 deaths from confirmed COVID-19 cases over a few weeks; these figures dropped rapidly following lockdown. Until October 2021, SARS-CoV-2 circulation was modulated by non-pharmacological preventive measures. The subsequent relaxation of these measures led to a wide circulation of the omicron variant, increasing the number of cases by three-fold. The high vaccination coverage against COVID-19 introduced decisive changes in the epidemiology of the disease, reducing to less than 2%, 0.1%, and 0.5% the cases requiring hospitalization, intensive care unit admission, or that died, respectively. CONCLUSIONS: Initial lockdown and non-pharmacological preventive measures helped control SARS-CoV-2 transmission until vaccination was extended. Vaccination achieved a decisive reduction of the COVID-19 severity and lethality. |
format | Online Article Text |
id | pubmed-10498135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Gobierno de Navarra. Departamento de Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-104981352023-09-14 Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022 Casado, Itziar Cenoz, Manuel García Egüés, Nerea Burgui, Cristina Martínez-Baz, Iván Castilla, Jesús An Sist Sanit Navar Artículos Originales BACKGROUND: Between February 2020 and September 2022, SARS-CoV-2 has circulated uninterruptedly throughout Spain. This study analyses COVID-19 infections, hospitalizations, and deaths in Navarre. METHODS: Enhanced epidemiological surveillance and results of seroepidemiological surveys were used to analyze COVID-19 infections, hospitalizations, and deaths, based on the vaccination coverage and other preventive measures applied from February 2020 to September 2022. RESULTS: A total of 295,424 COVID-19 cases were confirmed (45% of the population in Navarre); 8,594 required hospital admission (1.3%), 832 were admitted to intensive care units (1.3‰) and 1,725 died (2.6‰). Over the first wave of the pandemic, there were 1,934 hospitalizations and 529 deaths from confirmed COVID-19 cases over a few weeks; these figures dropped rapidly following lockdown. Until October 2021, SARS-CoV-2 circulation was modulated by non-pharmacological preventive measures. The subsequent relaxation of these measures led to a wide circulation of the omicron variant, increasing the number of cases by three-fold. The high vaccination coverage against COVID-19 introduced decisive changes in the epidemiology of the disease, reducing to less than 2%, 0.1%, and 0.5% the cases requiring hospitalization, intensive care unit admission, or that died, respectively. CONCLUSIONS: Initial lockdown and non-pharmacological preventive measures helped control SARS-CoV-2 transmission until vaccination was extended. Vaccination achieved a decisive reduction of the COVID-19 severity and lethality. Gobierno de Navarra. Departamento de Salud 2023-08-16 /pmc/articles/PMC10498135/ /pubmed/37594061 http://dx.doi.org/10.23938/ASSN.1044 Text en https://creativecommons.org/licenses/by-sa/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons (CC BY-SA 4.0) |
spellingShingle | Artículos Originales Casado, Itziar Cenoz, Manuel García Egüés, Nerea Burgui, Cristina Martínez-Baz, Iván Castilla, Jesús Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022 |
title | Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022 |
title_full | Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022 |
title_fullStr | Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022 |
title_full_unstemmed | Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022 |
title_short | Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022 |
title_sort | infecciones, hospitalizaciones y mortalidad por covid-19 en navarra entre febrero de 2020 y septiembre de 2022 |
topic | Artículos Originales |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498135/ https://www.ncbi.nlm.nih.gov/pubmed/37594061 http://dx.doi.org/10.23938/ASSN.1044 |
work_keys_str_mv | AT casadoitziar infeccioneshospitalizacionesymortalidadporcovid19ennavarraentrefebrerode2020yseptiembrede2022 AT cenozmanuelgarcia infeccioneshospitalizacionesymortalidadporcovid19ennavarraentrefebrerode2020yseptiembrede2022 AT eguesnerea infeccioneshospitalizacionesymortalidadporcovid19ennavarraentrefebrerode2020yseptiembrede2022 AT burguicristina infeccioneshospitalizacionesymortalidadporcovid19ennavarraentrefebrerode2020yseptiembrede2022 AT martinezbazivan infeccioneshospitalizacionesymortalidadporcovid19ennavarraentrefebrerode2020yseptiembrede2022 AT castillajesus infeccioneshospitalizacionesymortalidadporcovid19ennavarraentrefebrerode2020yseptiembrede2022 |